The Canadian PressMarch 20, 2014 11:34
LITTLE ROCK, Ark. - The Arkansas Supreme Court tossed out a $1.2 billion judgment against Johnson
The high court ruled the state's Medicaid fraud law, which formed the basis of Arkansas' lawsuit, regulates health care facilities and that drug manufacturers, including Johnson
The state alleged that the companies didn't properly communicate Risperdal's risks and marketed it for off-label use, calling the practices fraudulent.